Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 38 min ago
PreprintAll rights reservedbioRxiv

Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics

  • T. Vazquez
  • M. Cuevas-martinez
  • N. Billiald
  • F. Porsch
  • F.-Z. Sadddouk
  • M. Sion
  • L. Laurens
  • C. Albalaa
  • L. Zentilin
  • L. Peil
  • J. Teyra
  • T. Bouceba
10 more authors
  • I. Leleu
  • S. Pied
  • M. Ustav
  • A. Tedgui
  • S. Zacchigna
  • R. Le Grand
  • M. Rosenzwajg
  • Z. Mallat
  • C. J. Binder
  • D. Klatzmann1
  1. 1Sorbonne Universite, INSERM, UMRS959 - 75005 Paris, France
Read full textPDFDOICite

Related

  1. Bispecific antibodies targeting TL1A and IL-12/23p40 suppress pathogenic Th1/Th17 responses and ameliorate colitis in mice
    Xia Li, Hao Peng, Feng Hao +3
    iSciencePeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCell PressCrossrefEurope PMC
  2. 211 A discovery-to-therapeutics platform for functional antibody targeting of complex membrane-embedded tumor antigens: validation with claudin family members
    Tanel Mahlakõiv, Nayana Gaur, Siret Tahk +8
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  3. A bispecific antibody targeting a membrane-proximal ASGPR1 region promotes TNF-α recruitment and uptake
    X. Song, S. Li, A. HaShan +4
    bioRxivPreprintCC BY-NCFull textImmunologybioRxiv
  4. Suramin inspires next-generation broad-spectrum antiviral design targeting RdRps
    Arwen Baer, Ge Yang, Fan Bu +1
    PLOS PathogensPeer-reviewedCC BY 4.0Full textMicrobiologyPLOS
  5. Activation of α7 Nicotinic Acetylcholine Receptor Inhibits Neutrophil ex vivo Swarming and Pulmonary Recruitment in Inflamed Mice through an Integrin αMβ2-dependent Mechanism
    J. L. Casteel, T. Phillips, S. Singh +5
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv

Cite

BibTeXRIS
BibTeX
@misc{vazquez2026targeting,
  title = {{Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics}},
  author = {T. Vazquez and M. Cuevas-martinez and N. Billiald and F. Porsch and F.-Z. Sadddouk and M. Sion and L. Laurens and C. Albalaa and L. Zentilin and L. Peil and J. Teyra and T. Bouceba and I. Leleu and S. Pied and M. Ustav and A. Tedgui and S. Zacchigna and R. Le Grand and M. Rosenzwajg and Z. Mallat and C. J. Binder and D. Klatzmann},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.10.750022},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.10.750022v1},
}
RIS
TY  - UNPB
TI  - Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics
AU  - T. Vazquez
AU  - M. Cuevas-martinez
AU  - N. Billiald
AU  - F. Porsch
AU  - F.-Z. Sadddouk
AU  - M. Sion
AU  - L. Laurens
AU  - C. Albalaa
AU  - L. Zentilin
AU  - L. Peil
AU  - J. Teyra
AU  - T. Bouceba
AU  - I. Leleu
AU  - S. Pied
AU  - M. Ustav
AU  - A. Tedgui
AU  - S. Zacchigna
AU  - R. Le Grand
AU  - M. Rosenzwajg
AU  - Z. Mallat
AU  - C. J. Binder
AU  - D. Klatzmann
PY  - 2026
DA  - 2026/09/10
PB  - bioRxiv
DO  - 10.64898/2026.09.10.750022
UR  - https://www.biorxiv.org/content/10.64898/2026.09.10.750022v1
ER  -